Old Web
English
Sign In
Acemap
>
authorDetail
>
Andrew Eisen
Andrew Eisen
Acorda Therapeutics, Inc.
Medicine
Heart failure
Anesthesia
Internal medicine
Diabetes mellitus
3
Papers
53
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical Trials
2017
Clinical Pharmacology & Therapeutics
Diane M. Longo
Grant T. Generaux
Brett A. Howell
Scott Q. Siler
Daniel J. Antoine
Donald Button
Anthony O. Caggiano
Andrew Eisen
Jennifer Iaci
Ric Stanulis
Tom J. Parry
Merrie Mosedale
Paul B. Watkins
Show All
Source
Cite
Save
Citations (25)
Species-specific effects of neuregulin-1β (cimaglermin alfa) on glucose handling in animal models and humans with heart failure
2017
Toxicology and Applied Pharmacology
Zhihong Huang
Douglas B. Sawyer
Erika L. Troy
Corissa McEwen
John H. Cleator
Abigail Murphy
Anthony O. Caggiano
Andrew Eisen
Tom J. Parry
Show All
Source
Cite
Save
Citations (1)
A Phase I, Single Ascending Dose Study of Cimaglermin Alfa (Neuregulin 1β3) in Patients With Systolic Dysfunction and Heart Failure
2016
JACC: Basic to Translational Science
Daniel J. Lenihan
Sarah Anderson
Carrie Geisberg Lenneman
Evan L. Brittain
James A.S. Muldowney
Lisa A. Mendes
Ping Z. Zhao
Jennifer Iaci
Stephen Frohwein
Ronald Zolty
Andrew Eisen
Douglas B. Sawyer
Anthony O. Caggiano
Show All
Source
Cite
Save
Citations (27)
1